Reducing Dscam1 diversity decreases adult lifespan in an exon-specific manner, Related to Fig 3. by Haiyang Dong (4783608)

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Experimental treatments and design for cycling irrigation sequence (CS) and silicon fertilizer spraying frequency (SFSF). by Jieru Zhao (21262027)

Subjects:

Clinical outcomes and COVID-19 treatment during acute illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Association of knee OA AMVF patients with continuous variables. by Izzatul Nadiah Zolkiply (19681460)

Subjects:

Association of categorical variables with AMVF status of knee OA patients (n = 76). by Izzatul Nadiah Zolkiply (19681460)

Subjects:

Multivariable logistic regression analysis on the variables associated with AMVF in knee OA patients (n = 76). by Izzatul Nadiah Zolkiply (19681460)

Subjects:

Clinico-demographic characteristics of knee OA patients (n = 76). by Izzatul Nadiah Zolkiply (19681460)

Subjects:

Table 3_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.docx by Linda S. Barter (21466916)

Image 2_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg by Linda S. Barter (21466916)

Image 1_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg by Linda S. Barter (21466916)

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. by Annaëlle Le Steunf (19838110)

Treatment of cancer cells with vitamin D3 induced death <i>a.</i> by Vidya G. Bettada (22208808)

The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. by Marc Van Der Hofstadt (1423027)

Patient Example. by James M. Friedman (22522150)

Subjects:

Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

“…Group differences were tested with general linear models.</p><p dir="ltr"><b>Results: </b>No significant differences were found between people with and without HVDs on any of the measures. …”

This is the raw data used for this study. by James M. Friedman (22522150)

Subjects:

Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

Subjects:

Patient Demographics. by James M. Friedman (22522150)

Subjects:

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

Subjects: